Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: the LOCAL trial

Eur Heart JPublished Randomised controlled trial

Authors' conclusion

Unlike fentanyl, lignocaine does not impair the bioavailability or delay the antiplatelet effect of ticagrelor. Both drugs were well tolerated and effective with a high level of patient satisfaction for procedural analgesia.

Study context

Population
Patients with unstable angina or NSTEMI undergoing coronary angiography with ticagrelor loadingPK/PD analyses
Participants
70 patients
Comparison
Fentanyl vs Lignocaine

Primary result

As reported in the abstract

Pharmacokinetics and pharmacodynamics of ticagrelor
GroupPlasma ticagrelor 2 h post-loadingAUC ticagrelorAUC active metaboliteActivated GP IIb/IIIa expression at 60 min (MFI)P-selectin expression at 60 min (MFI)High on-treatment platelet reactivity, Multiplate, 60 minHigh on-treatment platelet reactivity, VerifyNow, 120 minHigh on-treatment platelet reactivity, VASP, 120 min
Fentanyl598 ng/mL1228 ng h/mL201 ng h/mL282943941%30%37%
Lignocaine1008 ng/mL2753 ng h/mL447 ng h/mL14262119%3%6%

Plasma ticagrelor 2 h post-loading

Fentanyl598 ng/mL
Lignocaine1008 ng/mL

AUC ticagrelor

Fentanyl1228 ng h/mL
Lignocaine2753 ng h/mL

AUC active metabolite

Fentanyl201 ng h/mL
Lignocaine447 ng h/mL

Activated GP IIb/IIIa expression at 60 min (MFI)

Fentanyl2829
Lignocaine1426

P-selectin expression at 60 min (MFI)

Fentanyl439
Lignocaine211

High on-treatment platelet reactivity, Multiplate, 60 min

Fentanyl41%
Lignocaine9%

High on-treatment platelet reactivity, VerifyNow, 120 min

Fentanyl30%
Lignocaine3%

High on-treatment platelet reactivity, VASP, 120 min

Fentanyl37%
Lignocaine6%
  • Fentanyl vs Lignocaine: P = 0.014 — plasma ticagrelor 2 h
  • Fentanyl vs Lignocaine: P < 0.001 — AUC ticagrelor
  • Fentanyl vs Lignocaine: P = 0.001 — AUC active metabolite
  • Fentanyl vs Lignocaine: P = 0.006 — GP IIb/IIIa
  • Fentanyl vs Lignocaine: P = 0.001 — P-selectin
  • Fentanyl vs Lignocaine: P = 0.002 — HPR Multiplate
  • Fentanyl vs Lignocaine: P = 0.003 — HPR VerifyNow
  • Fentanyl vs Lignocaine: P = 0.002 — HPR VASP

Safety

Tolerability

Both drugs well tolerated with high patient satisfaction

Original publication

Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: the LOCAL trial. Eur Heart J. Published 23 August 2021. doi:10.1093/eurheartj/ehab557

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.